Omenn Syndrome (OS)
Publisher
Springer New York
Reference19 articles.
1. Aleman K, Noordzij JG, de Groot R, van Dongen JJ, Hartwig NG. Reviewing Omenn syndrome. Eur J Pediatr. 2001;160:718–25.
2. Bernstein RM, Schluter SF, Lake DF, Marchalonis JJ. Evolutionary conservation and molecular cloning of the recombinase activating gene 1. Biochem Biophys Res Commun. 1994;205:687–92.
3. Capo V, Castiello MC, Fontana E, et al. Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation. J Allergy Clin Immunol. 2018;142: 928–41.e8
4. Cassani B, Poliani PL, Moratto D, et al. Defect of regulatory T cells in patients with Omenn syndrome. J Allergy Clin Immunol. 2010;125:209–16.
5. Harville TO, Adams DM, Howard TA, Ware RE. Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome. J Clin Immunol. 1997;17:322–32.